-
1
-
-
0242654867
-
Blood Pressure Lowering Treatment Trialists' Collaboration Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomized trials
-
Turnbull F, Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet 2003; 362:1527-1535.
-
(2003)
Lancet
, vol.362
, pp. 1527-1535
-
-
Turnbull, F.1
-
2
-
-
52149090673
-
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: A meta-analysis
-
Reboldi G, Angeli F, Cavallini C, Gentile G, Mancia G, Verdecchia P. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis. J Hypertens 2008; 26:1282-1289.
-
(2008)
J Hypertens
, vol.26
, pp. 1282-1289
-
-
Reboldi, G.1
Angeli, F.2
Cavallini, C.3
Gentile, G.4
Mancia, G.5
Verdecchia, P.6
-
3
-
-
0038203004
-
Cardiovascular prevention and blood pressure reduction: A quantitative overview updated until 1 March
-
Staessen JA, Wang JG, Thijs L. Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003. J Hypertens 2003; 21:1055-1076.
-
(2003)
J Hypertens
, vol.2003
, Issue.21
, pp. 1055-1076
-
-
Staessen, J.A.1
Wang, J.G.2
Thijs, L.3
-
4
-
-
34147116836
-
Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system
-
Turnbull F, Neal B, Pfeffer M, Kostis J, Algert C, Woodward M, et al. Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. J Hypertens 2007; 25:951-958.
-
(2007)
J Hypertens
, vol.25
, pp. 951-958
-
-
Turnbull, F.1
Neal, B.2
Pfeffer, M.3
Kostis, J.4
Algert, C.5
Woodward, M.6
-
5
-
-
42949112210
-
HYVET StudyGroup. Treatment ofhypertensionin patients 80 years of age or older
-
Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al., HYVET StudyGroup. Treatment ofhypertensionin patients 80 years of age or older. N Engl J Med 2008; 358:1887-1898.
-
(2008)
N Engl J Med
, vol.358
, pp. 1887-1898
-
-
Beckett, N.S.1
Peters, R.2
Fletcher, A.E.3
Staessen, J.A.4
Liu, L.5
Dumitrascu, D.6
-
6
-
-
64949190067
-
Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: A meta-analysis
-
Verdecchia P, Angeli F, Cavallini C, Gattobigio R, Gentile G, Staessen JA, Reboldi G. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis. Eur Heart J 2009; 30:679-688.
-
(2009)
Eur Heart J
, vol.30
, pp. 679-688
-
-
Verdecchia, P.1
Angeli, F.2
Cavallini, C.3
Gattobigio, R.4
Gentile, G.5
Staessen, J.A.6
Reboldi, G.7
-
7
-
-
0029960897
-
Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials
-
Moser M, Hebert PR. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996; 27:1214-1218.
-
(1996)
J Am Coll Cardiol
, vol.27
, pp. 1214-1218
-
-
Moser, M.1
Hebert, P.R.2
-
8
-
-
0037160968
-
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
-
DOI 10.1016/S0140-6736(02)08089-3
-
Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al., LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002; 359:995-1003. (Pubitemid 34286536)
-
(2002)
Lancet
, vol.359
, Issue.9311
, pp. 995-1003
-
-
Dahlof, B.1
Devereux, R.B.2
Kjeldsen, S.E.3
Julius, S.4
Beevers, G.5
De Faire, U.6
Fyhrquist, F.7
Ibsen, H.8
Kristiansson, K.9
Lederballe-Pedersen, O.10
Lindholm, L.H.11
Nieminen, M.S.12
Omvik, P.13
Oparil, S.14
Wedel, H.15
-
9
-
-
0344373794
-
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor of calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
-
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
-
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor of calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288:2981-2997.
-
(2002)
JAMA
, vol.288
, pp. 2981-2997
-
-
|